Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Descartes-25 |
Synonyms | |
Therapy Description |
Limited information is currently available on Descartes-25, a putative BCMA and IL-12-targeting therapy (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Descartes-25 | Descartes 25|Descartes25 | Limited information is currently available on Descartes-25, a putative BCMA and IL-12-targeting therapy (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05113342 | Phase Ib/II | Descartes-25 | Descartes-25 in Relapsed/Refractory Multiple Myeloma | Terminated | USA | TUR | 0 |